Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings
Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
